iShares Biotechnology ETF (NASDAQ:IBB) Hits New 1-Year High – What’s Next?

Posted by Brenda Bartman on Jul 6th, 2026

Shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $196.03 and last traded at $196.03, with a volume of 7850 shares. The stock had previously closed at $195.70.

iShares Biotechnology ETF Trading Down 0.4%

The business has a fifty day moving average price of $173.18 and a 200-day moving average price of $171.86.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were given a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%.

Institutional Trading of iShares Biotechnology ETF

A number of institutional investors have recently made changes to their positions in IBB. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Basepoint Wealth LLC bought a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $29,000. Copia Wealth Management purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Finally, Caitlin John LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Company Profile

(Get Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.